| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.0000020548.60110.76 |
| P698 | PubMed publication ID | 12057982 |
| P50 | author | Anthony P Davenport | Q43161913 |
| P2093 | author name string | J C Clark | |
| P J Kirkpatrick | |||
| J D Pickard | |||
| E A Warburton | |||
| P L Weissberg | |||
| H A Jones | |||
| P Johnström | |||
| T D Fryer | |||
| J H F Rudd | |||
| B N Arch | |||
| N Antoun | |||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 2708-2711 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography | |
| P478 | volume | 105 |
| Q34694001 | (18)F-FDG PET and vascular inflammation: time to refine the paradigm? |
| Q35929739 | (18)F-FDG PET imaging in detection of radiation-induced vascular disease in lymphoma survivors |
| Q34506127 | (18)F-FDG PET imaging of murine atherosclerosis: association with gene expression of key molecular markers |
| Q37201445 | (18)F-FDG imaging of human atherosclerotic carotid plaques reflects gene expression of the key hypoxia marker HIF-1α. |
| Q39878866 | (18)F-fluorodeoxyglucose PET imaging of coronary atherosclerosis and plaque inflammation |
| Q35896196 | (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: A proof-of-principle study |
| Q42616070 | 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis |
| Q45821608 | 18F-FDG PET and intravascular ultrasonography (IVUS) images compared with histology of atherosclerotic plaques: 18F-FDG accumulates in foamy macrophages |
| Q47440392 | 18F-FDG PET-CT uptake is a feature of both normal diameter and aneurysmal aortic wall and is not related to aneurysm size. |
| Q48533857 | 18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaques. |
| Q38836629 | 18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients |
| Q46954895 | 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries |
| Q30842993 | 18F-Fluoride and 18F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic Stroke: Case-Control Study |
| Q39315993 | 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial |
| Q36311889 | 18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors |
| Q35777600 | 64Cu-DOTATATE PET/MRI for Detection of Activated Macrophages in Carotid Atherosclerotic Plaques: Studies in Patients Undergoing Endarterectomy |
| Q36329223 | 68Ga-DOTATATE PET/CT for the detection of inflammation of large arteries: correlation with18F-FDG, calcium burden and risk factors. |
| Q79538242 | 99mTc-Annexin A5 for noninvasive characterization of atherosclerotic lesions: imaging and histological studies in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits |
| Q46748719 | 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. |
| Q60916470 | A High-Resolution MRI Study of the Relationship Between Plaque Enhancement and Ischemic Stroke Events in Patients With Intracranial Atherosclerotic Stenosis |
| Q89108581 | A Pilot Trial to Examine the Changes in Carotid Arterial Inflammation in Renal Transplant Recipients as Assessed by 18F-Fluorodeoxyglucose (18F-FDG) Positron Emission Tomography Computed Tomography (PET/CT) |
| Q37285410 | A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study |
| Q38005672 | A molecular imaging primer: modalities, imaging agents, and applications |
| Q57740341 | Acute coronary syndromes, plaque vulnerability,and carotid artery disease |
| Q58115074 | Advances in coronary molecular imaging: Leveraging the power of image processing |
| Q30441467 | Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage. |
| Q38052020 | Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. |
| Q37284563 | Advances in molecular imaging of atherosclerotic vascular disease |
| Q37626229 | An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide |
| Q46387886 | An in vivo multimodal imaging study using MRI and PET of stem cell transplantation after myocardial infarction in rats. |
| Q53028275 | Analysis of Myocardial (18)F-FDG Uptake by PET/CT in the Patients with Different Dialectically Classified Coronary Heart Diseases (CHD). |
| Q30414631 | Anti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE study |
| Q48358241 | Aortic atheroma and adverse cerebral outcome: risk, diagnosis, and management options |
| Q46138309 | Aortic inflammation, as assessed by hybrid FDG-PET/CT imaging, is associated with enhanced aortic stiffness in addition to concurrent calcification |
| Q35851713 | Aortic ¹⁸F-FDG uptake in patients suffering from granulomatosis with polyangiitis |
| Q37038950 | Applications and software techniques for integrated cardiac multimodality imaging |
| Q64958730 | Applying the ordinal model of atherosclerosis to imaging science: a brief review. |
| Q47676328 | Arterial Inflammation Detected With 18 F-Fluorodeoxyglucose-Positron Emission Tomography in Rheumatoid Arthritis |
| Q38801508 | Arterial and Cellular Inflammation in Patients with CKD. |
| Q33624371 | Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. |
| Q38454054 | Arterial inflammation in bronchial asthma |
| Q37046942 | Arterial inflammation in patients with HIV. |
| Q46678565 | Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events |
| Q38397910 | Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification |
| Q51744048 | Assessment of atherosclerotic plaque activity in patients with sleep apnea using hybrid positron emission tomography/magnetic resonance imaging (PET/MRI): a feasibility study. |
| Q46375022 | Assessment of inactive, active and mixed atherosclerotic plaques by 18F-FDG-PET; an age group-based correlation with cardiovascular risk factors |
| Q37643812 | Association of Arterial and Lymph Node Inflammation With Distinct Inflammatory Pathways in Human Immunodeficiency Virus Infection |
| Q43124156 | Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study |
| Q53477839 | Atheroma roulette. |
| Q89801230 | Atherosclerosis Immunoimaging by Positron Emission Tomography |
| Q30364399 | Atherosclerosis and Nanotechnology: Diagnostic and Therapeutic Applications. |
| Q36390068 | Atherosclerosis imaging on the molecular level |
| Q36070404 | Atherosclerosis imaging: intravascular ultrasound |
| Q57924695 | Atherosclerosis regression |
| Q35092141 | Atherosclerotic plaque biomarkers: beyond the horizon of the vulnerable plaque |
| Q41854592 | Atherosclerotic plaque inflammation quantification using dynamic contrast-enhanced (DCE) MRI. |
| Q53246540 | Beyond stenosis: further progress in multi-modal evaluation of carotid disease. |
| Q33679420 | Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis |
| Q37228234 | Biological imaging of atherosclerosis: moving beyond anatomy |
| Q37762507 | Biomarkers of vulnerable atheromatous plaques: translational medicine perspectives. |
| Q90055871 | Biomimetic nanoparticle technology for cardiovascular disease detection and treatment |
| Q47397332 | CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET/CT in patients at risk for cardiovascular disease |
| Q41661011 | Cardiovascular disease in HIV: traditional and nontraditional risk factors. |
| Q42220130 | Cardiovascular implantable electronic device infection: delayed vs standard FDG PET-CT imaging |
| Q36841558 | Cardiovascular molecular imaging of apoptosis |
| Q37530107 | Cardiovascular molecular imaging: an overview |
| Q30470859 | Cardiovascular molecular imaging: focus on clinical translation |
| Q34090920 | Carotid Artery FDG Uptake May Serve as a Biomarker for Cardiovascular Risk Stratification in Asymptomatic Adults |
| Q36204111 | Carotid arterial wall inflammation in peripheral artery disease is augmented by type 2 diabetes: a cross-sectional study |
| Q33617386 | Carotid atherosclerotic plaques standardised uptake values: software challenges and reproducibility. |
| Q53030795 | Carotid plaque inflammation assessed with (18)F-FDG PET/CT is higher in symptomatic compared with asymptomatic patients. |
| Q53168491 | Carotid plaque inflammation on 18F-fluorodeoxyglucose positron emission tomography predicts early stroke recurrence. |
| Q37484577 | Carotid-artery imaging in the diagnosis and management of patients at risk of stroke |
| Q35641545 | Cerebrovascular MRI: a review of state-of-the-art approaches, methods and techniques |
| Q53507962 | Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies. |
| Q45829652 | Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients |
| Q39255756 | Clinical Outcomes in Trials Evaluating Lipid-Lowering Drugs. |
| Q35167912 | Clinical biomarkers in drug discovery and development |
| Q89798553 | Clinical imaging of cardiovascular inflammation |
| Q45407413 | Combined application of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in early diagnosis of vulnerable carotid atherosclerotic plaques |
| Q50698610 | Comparison of 99mTc-annexin A5 with 18F-FDG for the detection of atherosclerosis in ApoE-/- mice. |
| Q35979279 | Comparison of Visceral Fat Measures with Cardiometabolic Risk Factors in Healthy Adults |
| Q53065955 | Comparison of fluorodeoxyglucose uptake in symptomatic carotid artery and stable femoral artery plaques. |
| Q37395788 | Comparison of synthetic high density lipoprotein (HDL) contrast agents for MR imaging of atherosclerosis |
| Q37043344 | Complementarity between (18)F-FDG PET/CT and Ultrasonography or Angiography in Carotid Plaque Characterization |
| Q36131805 | Comprehensive imaging of coronary artery disease: impact on contemporary treatment approaches |
| Q37385650 | Contrast ultrasound molecular imaging of inflammation in cardiovascular disease |
| Q47992578 | Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions |
| Q37462399 | Coronary CT angiography (CCTA) and advances in CT plaque imaging |
| Q53046789 | Coronary arterial atherosclerotic plaque imaging by contrast-enhanced computed tomography: fantasy or reality? |
| Q96304404 | Coronary inflammation: why searching, how to identify and treat it |
| Q30436195 | Correlation between arterial FDG uptake and biomarkers in peripheral artery disease. |
| Q38442451 | Current and future trends in multimodality imaging of coronary artery disease. |
| Q37998112 | Current imaging modalities for atherosclerosis. |
| Q51101683 | Delayed ¹⁸F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: results from the CAMONA study. |
| Q38573781 | Detecting the vulnerable plaque in patients |
| Q35080574 | Detection of inflamed atherosclerotic lesions with diadenosine-5',5'''-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography |
| Q53124084 | Detection of thoracic aortic prosthetic graft infection with 18F-fluorodeoxyglucose positron emission tomography/computed tomography. |
| Q34684088 | Detection of vulnerable atherosclerotic plaque and prediction of thrombosis events in a rabbit model using 18F-FDG -PET/CT |
| Q50125858 | Development of an inflammation imaging tracer, 111In-DOTA-DAPTA, targeting chemokine receptor CCR5 and preliminary evaluation in an ApoE-/- atherosclerosis mouse model |
| Q57761427 | Diabetes y enfermedad cardiovascular |
| Q35773021 | Diagnostic and clinical perspectives of fusion imaging in cardiology: is the total greater than the sum of its parts? |
| Q37838232 | Diagnostic and therapeutic strategies for small abdominal aortic aneurysms |
| Q57067440 | Diet-Modulated Lipoprotein Metabolism and Vascular Inflammation Evaluated by F-fluorodeoxyglucose Positron Emission Tomography |
| Q82104764 | Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study |
| Q48596641 | Dual cardiac-respiratory gated PET: implementation and results from a feasibility study. |
| Q45071762 | Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis. |
| Q37722436 | Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation |
| Q45241914 | Dual-gated cardiac PET-clinical feasibility study |
| Q87456522 | Editorial in response to: PET/CT evaluation of 18F-FDG uptake in pericoronary adipose tissue in patients with stable coronary artery disease: Independent predictor of atherosclerotic lesion formation? : Is there prognostic value in evaluation of 18F |
| Q34147045 | Effect of duration of fasting and diet on the myocardial uptake of F-18-2-fluoro-2-deoxyglucose (F-18 FDG) at rest |
| Q35534303 | Electrochemical impedance spectroscopy to characterize inflammatory atherosclerotic plaques |
| Q37390765 | Emergence of targeted molecular imaging in atherosclerotic cardiovascular disease |
| Q30450437 | Emerging diagnostic and therapeutic molecular imaging applications in vascular disease |
| Q37316651 | Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries |
| Q38067325 | Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography |
| Q44115645 | Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. |
| Q33908068 | Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis |
| Q30249617 | Evolving Role of Molecular Imaging with (18)F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism. |
| Q58805509 | F-FDG Uptake on PET/CT in Symptomatic versus Asymptomatic Carotid Disease: a Meta-Analysis |
| Q56342222 | F-NaF and F-FDG as molecular probes in the evaluation of atherosclerosis |
| Q37800428 | FDG PET imaging and cardiovascular inflammation. |
| Q43270438 | FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. |
| Q46934623 | FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries |
| Q46020690 | FDG-accumulating atherosclerotic plaques identified with 18F-FDG-PET/CT in 141 patients. |
| Q44937777 | Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant |
| Q37053606 | Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results |
| Q42814382 | Feasibility of simultaneous PET/MR in diet-induced atherosclerotic minipig: a pilot study for translational imaging |
| Q44639307 | Fluorodeoxyglucose Uptake in the Aortic Wall at PET/CT: Possible Finding for Active Atherosclerosis |
| Q79438471 | Fluorodeoxyglucose and calcium uptake in the vascular wall: clinically relevant or sugar-coated pill? |
| Q37165155 | Form to function: current and future roles for atherosclerosis imaging in drug development |
| Q48559001 | Fourth annual Mario S. Verani, MD Memorial Lecture: noninvasive imaging in coronary artery disease: changing roles, changing players |
| Q30533932 | Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance |
| Q46264613 | Fusion of positron emission tomography and coronary computed tomographic angiography identifies fluorine 18 fluorodeoxyglucose uptake in the left main coronary artery soft plaque |
| Q26738576 | Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography |
| Q55039757 | Gazing into smoldering volcanoes: precision cardiac imaging. |
| Q90577485 | Greater aortic inflammation and calcification in abdominal aortic aneurysmal disease than atherosclerosis: a prospective matched cohort study |
| Q38421038 | Hepatic FDG uptake is associated with future cardiovascular events in asymptomatic individuals with non-alcoholic fatty liver disease |
| Q36450213 | High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake. |
| Q44804684 | High-dose atorvastatin reduces periodontal inflammation: a novel pleiotropic effect of statins. |
| Q30532182 | High-resolution [18]fluorodeoxyglucose-positron emission tomography and coregistered magnetic resonance imaging of atherosclerotic plaque from a patient undergoing carotid endarterectomy. |
| Q35577419 | High-resolution imaging of human atherosclerotic carotid plaques with micro 18F-FDG PET scanning exploring plaque vulnerability |
| Q47723024 | High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging |
| Q53786578 | Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype. |
| Q53057426 | Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study. |
| Q35583807 | Human cellular inflammation in the pathology of acute cerebral ischaemia |
| Q53437727 | Hybrid PET/CT is greater than the sum of its parts. |
| Q42256348 | Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. |
| Q38725762 | Identification of early vascular calcification with (18)F-sodium fluoride: potential clinical application |
| Q44029089 | Identification of inflamed atherosclerotic lesions in vivo using PET-CT. |
| Q56986839 | Identification of interleukin-2 for imaging atherosclerotic inflammation |
| Q48859753 | Identifying high risk plaques prior to heart attack using PET-CT. |
| Q38088387 | Identifying high-risk asymptomatic carotid stenosis |
| Q45206166 | Image of an aneurysm of abdominal aorta with PET 18F-FDG |
| Q33704070 | Imaging Atherosclerosis in the Carotid Arteries with F-18-Fluoro-2-deoxy-D-glucose Positron Emission Tomography: Effect of Imaging Time after Injection on Quantitative Measurement |
| Q39003586 | Imaging High-Risk Atherosclerotic Plaques with PET. |
| Q26769824 | Imaging Modalities to Identity Inflammation in an Atherosclerotic Plaque |
| Q42013140 | Imaging RAGE expression in atherosclerotic plaques in hyperlipidemic pigs |
| Q38918899 | Imaging Subclinical Atherosclerosis: Where Do We Stand? |
| Q37755125 | Imaging and molecular biomarkers of vulnerable atheromatous plaques |
| Q27002916 | Imaging and nanomedicine in inflammatory atherosclerosis |
| Q30435383 | Imaging atherosclerosis and vulnerable plaque |
| Q37984849 | Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond |
| Q36434865 | Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. |
| Q35072987 | Imaging atherosclerosis with hybrid positron emission tomography/magnetic resonance imaging |
| Q37222163 | Imaging atherosclerotic plaque inflammation. |
| Q51945900 | Imaging biomarkers of atherosclerosis. |
| Q34109961 | Imaging biomarkers of cardiovascular disease |
| Q53015061 | Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. |
| Q33697215 | Imaging of atherosclerosis |
| Q38263804 | Imaging of atherosclerotic plaques in obesity: excessive fat accumulation, plaque progression and vulnerability |
| Q35562199 | Imaging of carotid artery disease: from luminology to function? |
| Q37681558 | Imaging of carotid artery vessel wall edema using T2-weighted cardiovascular magnetic resonance. |
| Q37832982 | Imaging of coronary inflammation with FDG-PET: feasibility and clinical hurdles |
| Q35861360 | Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. |
| Q38068347 | Imaging of inflammation and calcification in aortic stenosis |
| Q30804314 | Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data |
| Q80796551 | Imaging of unstable atherosclerotic lesions |
| Q38239604 | Imaging subclinical atherosclerosis: is it ready for prime time? A review |
| Q36892171 | Imaging techniques for the vulnerable coronary plaque. |
| Q37244485 | Imaging the cellular biology of the carotid plaque. |
| Q36728733 | Imaging the efficacy of anti-inflammatory liposomes in a rabbit model of atherosclerosis by non-invasive imaging |
| Q36169432 | Imaging the vertebral artery |
| Q41896880 | Impact of Fiber Structure on the Material Stability and Rupture Mechanisms of Coronary Atherosclerotic Plaques |
| Q33742608 | Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: A randomized controlled trial |
| Q44721656 | Impact of cardiovascular risk factors on vessel wall inflammation and calcified plaque burden differs across vascular beds: a PET-CT study |
| Q36083402 | Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake |
| Q33220185 | In vivo detection of macrophages in a rabbit atherosclerotic model by time-resolved laser-induced fluorescence spectroscopy |
| Q37157569 | In vivo molecular imaging of vascular stress |
| Q46268489 | In vivo non-invasive serial monitoring of FDG-PET progression and regression in a rabbit model of atherosclerosis |
| Q36803873 | Increased arterial inflammation in individuals with stage 3 chronic kidney disease |
| Q52965339 | Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate-to-severe psoriasis. |
| Q34543441 | Increased microvascularization and vessel permeability associate with active inflammation in human atheromata |
| Q44461721 | Indications of PET imaging |
| Q48032037 | Inflamed human carotid plaques evaluated by PET/CT exhibit increased temperature: insights from an in vivo study |
| Q27692593 | Inflammation and neovascularization intertwined in atherosclerosis: imaging of structural and molecular imaging targets |
| Q33719461 | Inflammation imaging in atherosclerosis |
| Q42400279 | Inflammation, Atherosclerosis and Coronary Artery Disease |
| Q38352448 | Inflammation, Atherosclerosis, and Coronary Artery Disease: PET/CT for the Evaluation of Atherosclerosis and Inflammation |
| Q37704941 | Integration of coronary anatomy and myocardial perfusion imaging |
| Q35586045 | Integrin-targeted imaging of inflammation in vascular remodeling |
| Q30744971 | Intracranial plaque enhancement in patients with cerebrovascular events on high-spatial-resolution MR images. |
| Q39874491 | Intravascular near-infrared fluorescence molecular imaging of atherosclerosis |
| Q42906639 | Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still "rusty?". |
| Q26741146 | Longitudinal imaging of the ageing mouse |
| Q47691747 | MRI of plaque characteristics and relationship with downstream perfusion and cerebral infarction in patients with symptomatic middle cerebral artery stenosis |
| Q35197135 | Magnetic resonance imaging of coronary atherosclerosis |
| Q36412642 | Management of extracranial carotid artery disease |
| Q56525056 | Measurement of Ga-DOTATOC Uptake in the Thoracic Aorta and Its Correlation with Cardiovascular Risk |
| Q36304339 | Mechanisms of disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis |
| Q36814420 | Metabolic imaging using PET. |
| Q38197343 | Methylglyoxal and glyoxalase I in atherosclerosis |
| Q57681456 | Microvessel Density But Not Neoangiogenesis Is Associated with 18F-FDG Uptake in Human Atherosclerotic Carotid Plaques |
| Q37196379 | Modern methods for imaging carotid atheroma |
| Q37629944 | Modified natural nanoparticles as contrast agents for medical imaging. |
| Q54967787 | Molecular Imaging of Atherosclerosis: A Clinical Focus. |
| Q64974312 | Molecular Imaging of Inflammation in Ischemic Heart Disease. |
| Q36700579 | Molecular cardiovascular imaging using scintigraphic methods |
| Q30484224 | Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation |
| Q37139934 | Molecular imaging of atherosclerosis |
| Q37822690 | Molecular imaging of atherosclerosis in translational medicine. |
| Q41819473 | Molecular imaging of atherosclerosis: clinical state-of-the-art |
| Q50072823 | Molecular imaging of atherosclerosis: spotlight on Raman spectroscopy and surface-enhanced Raman scattering. |
| Q38700322 | Molecular imaging of high-risk atherosclerotic plaques: is it clinically translatable? |
| Q30479243 | Molecular imaging of inflammation and intraplaque vasa vasorum: a step forward to identification of vulnerable plaques? |
| Q30446268 | Molecular imaging of inflammation in atherosclerosis |
| Q34260475 | Molecular imaging of plaques in coronary arteries with PET and SPECT. |
| Q40361537 | Molecular imaging of vulnerable atherosclerotic plaques |
| Q37177648 | Molecular imaging will replace perfusion imaging: The impossible dream |
| Q47114838 | Molecular targets in aortic aneurysm for establishing novel management paradigms |
| Q35936423 | Molecular, cellular and functional imaging of atherothrombosis |
| Q83097392 | Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice |
| Q46225933 | Monitoring plaque composition: is it worthwile? |
| Q42076960 | Monitoring plaque inflammation in atherosclerotic rabbits with an iron oxide (P904) and (18)F-FDG using a combined PET/MR scanner. |
| Q58592672 | Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3) |
| Q50082613 | Monocyte and haematopoietic progenitor reprogramming as common mechanism underlying chronic inflammatory and cardiovascular diseases. |
| Q27006827 | Monocytes as regulators of inflammation and HIV-related comorbidities during cART |
| Q38095643 | Multi-modal imaging technologies in cardiovascular risk assessment |
| Q60923329 | Multimodal and Multiscale Analysis Reveals Distinct Vascular, Metabolic and Inflammatory Components of the Tissue Response to Limb Ischemia |
| Q35936550 | Multimodal clinical imaging to longitudinally assess a nanomedical anti-inflammatory treatment in experimental atherosclerosis |
| Q30438207 | Multimodality cardiovascular molecular imaging, Part II |
| Q33395380 | Multimodality image registration with software: state-of-the-art |
| Q36218239 | Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries |
| Q90272523 | Multiparametric Molecular Imaging of Atherosclerosis: Insights Into Disease Pathology and Risk |
| Q53200542 | Myo-Myo: Yes, papa. Eating sugar? No, papa! Modulating the myocardial menu for imaging coronary inflammation... |
| Q30430958 | NIH workshop on clinical translation of molecular imaging probes and technology--meeting report. |
| Q37569289 | Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions |
| Q43153036 | Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. |
| Q91579180 | Nanoparticle-Aided Characterization of Arterial Endothelial Architecture during Atherosclerosis Progression and Metabolic Therapy |
| Q38089761 | Nanotechnology in the diagnosis of atherosclerotic disease |
| Q41033772 | Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT. |
| Q27011866 | New SPECT and PET radiopharmaceuticals for imaging cardiovascular disease |
| Q51730474 | New methods to image unstable atherosclerotic plaques. |
| Q38000174 | Non-FDG imaging of atherosclerosis: will imaging of MMPs assess plaque vulnerability? |
| Q26824883 | Non-invasive anatomic and functional imaging of vascular inflammation and unstable plaque |
| Q35172896 | Non-invasive detection of vulnerable coronary plaque |
| Q27011260 | Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease |
| Q26992143 | Non-invasive imaging of atherosclerosis |
| Q33244720 | Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation |
| Q58616177 | Non-invasive imaging of the coronary arteries |
| Q27020959 | Non-invasive vulnerable plaque imaging: how do we know that treatment works? |
| Q39762487 | Non-specific binding of [18F]FDG to calcifications in atherosclerotic plaques: experimental study of mouse and human arteries |
| Q37850313 | Noninvasive Positron Emission Tomography Imaging of Coronary Arterial Inflammation |
| Q55339099 | Noninvasive aortic imaging. |
| Q42722497 | Noninvasive assessment of hypoxia in rabbit advanced atherosclerosis using ¹⁸F-fluoromisonidazole positron emission tomographic imaging |
| Q52578262 | Noninvasive detection of macrophages using a nanoparticulate contrast agent for computed tomography. |
| Q53135348 | Noninvasive imaging in cardiovascular therapy: the promise of coronary arterial ¹⁸F-sodium fluoride uptake as a marker of plaque biology. |
| Q37398580 | Noninvasive imaging of atheromatous carotid plaques. |
| Q46535642 | Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography |
| Q36307762 | Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease |
| Q26781838 | Nuclear Molecular Imaging for Vulnerable Atherosclerotic Plaques |
| Q33624365 | Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. |
| Q41785188 | PET Cell Tracking Using 18F-FLT is Not Limited by Local Reuptake of Free Radiotracer. |
| Q26750798 | PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology |
| Q52668221 | PET Imaging of Cardiac Hypoxia: Hitting Hypoxia Where It Hurts. |
| Q90131126 | PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation |
| Q37357099 | PET and MRI in cardiac imaging: from validation studies to integrated applications |
| Q37896144 | PET and PET/CT in cardiovascular disease |
| Q37873382 | PET imaging of aortic atherosclerosis: Is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality? |
| Q38326673 | PET imaging of atherosclerosis. |
| Q38218902 | PET imaging of inflammation in atherosclerosis |
| Q48031424 | PET imaging of the neurovascular interface in cerebrovascular disease |
| Q37764708 | PET in Cerebrovascular Disease |
| Q92071803 | PET-Based Imaging of Ischemic Heart Disease |
| Q61755946 | PET/CT and PET/MRI in Neurology: Infection/Inflammation |
| Q43134225 | PET/CT imaging of atherosclerotic blood vessel alterations |
| Q39334798 | PET/MR imaging of atherosclerosis: initial experience and outlook |
| Q92913591 | PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity |
| Q37449411 | PET/MRI of Hypoxic Atherosclerosis Using 64Cu-ATSM in a Rabbit Model |
| Q99617678 | PET/MRI of atherosclerosis |
| Q30456937 | PET/MRI: current state of the art and future potential for cardiovascular applications |
| Q37038775 | Pathophysiology and management of cardiovascular disease in patients with HIV |
| Q37578256 | Patients with an Inflamed Atherosclerotic Plaque have Increased Levels of Circulating Inflammatory Markers. |
| Q27324089 | Periaortic brown adipose tissue as a major determinant of [¹⁸F]-fluorodeoxyglucose vascular uptake in atherosclerosis-prone, apoE-/- mice |
| Q64107238 | Perspectives on Small Animal Radionuclide Imaging; Considerations and Advances in Atherosclerosis |
| Q38469591 | Pioglitazone modulates vascular inflammation in atherosclerotic rabbits noninvasive assessment with FDG-PET-CT and dynamic contrast-enhanced MR imaging |
| Q53018280 | Plaque Thrombosis is Reduced by Attenuating Plaque Inflammation with Pioglitazone and is Evaluated by Fluorodeoxyglucose Positron Emission Tomography. |
| Q38605303 | Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM) on PET imaging of atherosclerosis |
| Q36426832 | Positive association between serum level of glyceraldehyde-derived advanced glycation end products and vascular inflammation evaluated by [(18)F]fluorodeoxyglucose positron emission tomography |
| Q36792762 | Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms |
| Q26824610 | Positron emission tomography imaging of atherosclerosis |
| Q37050963 | Positron emission tomography imaging of coronary atherosclerosis |
| Q38167348 | Positron emission tomography of the vulnerable atherosclerotic plaque in man--a contemporary review |
| Q38731444 | Potential of α7 nicotinic acetylcholine receptor PET imaging in atherosclerosis |
| Q37438144 | Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview |
| Q36319279 | Pre-pulseless Takayasu's arteritis evaluated with 18F-FDG positron emission tomography and gadolinium-enhanced magnetic resonance angiography |
| Q48332308 | Predictive medicine: towards a multi-parametric imaging for a personal risk stratification. |
| Q33956714 | Predictors of change in carotid atherosclerotic plaque inflammation and burden as measured by 18-FDG-PET and MRI, respectively, in the dal-PLAQUE study |
| Q51287844 | Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle. |
| Q37200626 | Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC). |
| Q90316736 | Pretreatment tumor-related leukocytosis misleads positron emission tomography-computed tomography during lymph node staging in gynecological malignancies |
| Q33994603 | Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: FDG-PET and CT imaging study. |
| Q44285948 | Prevalence of coronary artery calcium scores and silent myocardial ischaemia was similar in Indian Asians and European whites in a cross-sectional study of asymptomatic subjects from a U.K. population (LOLIPOP-IPC). |
| Q30464390 | Progress in atherosclerotic plaque imaging |
| Q45969236 | Progression of coronary atherosclerosis in stable patients with ultrasonic features of high-risk plaques. |
| Q34861181 | Protein cage nanoparticles bearing the LyP-1 peptide for enhanced imaging of macrophage-rich vascular lesions. |
| Q64108968 | Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement |
| Q34668556 | Psoriatic arthritis and sacroiliitis are associated with increased vascular inflammation by 18-fluorodeoxyglucose positron emission tomography computed tomography: baseline report from the Psoriasis Atherosclerosis and Cardiometabolic Disease Initia |
| Q53510699 | Quantifying [¹⁸F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction. |
| Q36999889 | Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system |
| Q46339979 | Quantitative assessment of glucose metabolism in the vessel wall of abdominal aortic aneurysms: correlation with histology and role of partial volume correction |
| Q37283646 | Quantum dot mediated imaging of atherosclerosis |
| Q33943594 | Radionuclide imaging of myocardial metabolism |
| Q37196226 | Radionuclide imaging: a molecular key to the atherosclerotic plaque |
| Q33719962 | Rationale and design of dal-PLAQUE: a study assessing efficacy and safety of dalcetrapib on progression or regression of atherosclerosis using magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography/computed tomography |
| Q38156683 | Recent advances in metabolic imaging |
| Q26740304 | Recent advances in pathogenesis, assessment, and treatment of atherosclerosis |
| Q38233595 | Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging. |
| Q91955416 | Recipient c-Kit Lineage Cells Repopulate Smooth Muscle Cells of Transplant Arteriosclerosis in Mouse Models |
| Q84523181 | Reduced myocardial 18F-FDG uptake after calcium channel blocker administration. Initial observation for a potential new method to improve plaque detection |
| Q50957944 | Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomogra |
| Q37282953 | Relationship Between Measures of Adiposity, Arterial Inflammation, and Subsequent Cardiovascular Events |
| Q35303221 | Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study |
| Q33949993 | Reproducibility of black blood dynamic contrast-enhanced magnetic resonance imaging in aortic plaques of atherosclerotic rabbits |
| Q38261508 | Risk of coronary heart disease in patients with HIV infection |
| Q57120868 | Role of PET/CT in the Evaluation of Aortic Disease |
| Q34120778 | Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial |
| Q48566449 | Second Annual Mario S. Verani, MD, Memorial Lecture: Nuclear cardiology, the next 10 years |
| Q36326833 | Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study |
| Q42484107 | Silybin and dehydrosilybin decrease glucose uptake by inhibiting GLUT proteins |
| Q38092246 | Small animal positron emission tomography imaging and in vivo studies of atherosclerosis |
| Q41412833 | Smooth Muscle Enriched Long Noncoding RNA (SMILR) Regulates Cell Proliferation |
| Q46672751 | Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients |
| Q37714570 | Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. |
| Q42701584 | Subclinical vasculitis as a potential mechanism to explain the heightened cardiovascular risk in rheumatoid arthritis |
| Q84148937 | Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet |
| Q35626038 | Symptomatic and asymptomatic carotid artery plaque |
| Q36141760 | Systemic Atherosclerotic Inflammation Following Acute Myocardial Infarction: Myocardial Infarction Begets Myocardial Infarction |
| Q35171276 | Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study |
| Q89737559 | Systemic atherosclerotic plaque vulnerability in patients with Coronary Artery Disease with a single Whole Body FDG PET-CT scan |
| Q37104019 | Takayasu's disease: a review |
| Q57288605 | Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon |
| Q37787083 | Target: ligand interactions of the vascular endothelium. Implications for molecular imaging in inflammation |
| Q89346966 | Targeting activated macrophages to identify the vulnerable atherosclerotic plaque |
| Q37175720 | Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis |
| Q47831315 | Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model. |
| Q36090166 | Targeting the vulnerable plaque: the evolving role of nuclear imaging |
| Q49909152 | Technical considerations for quantification of (18)F-FDG uptake in carotid atherosclerosis |
| Q46535633 | The atherosclerotic plaque: a healthy challenge to the limits of nuclear imaging |
| Q37296851 | The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. |
| Q27026331 | The development, past achievements, and future directions of brain PET |
| Q89363407 | The dream of imaging coronary artery inflammation with FDG PET/CT imaging |
| Q41882821 | The evolving roles of nuclear cardiology |
| Q38800754 | The future of imaging in cardiovascular disease intervention trials: 2017 and beyond |
| Q36745053 | The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease |
| Q34372598 | The importance of GLUT3 for de novo lipogenesis in hypoxia-induced lipid loading of human macrophages |
| Q36496252 | The pathobiology of the vessel wall: implications for imaging |
| Q38071561 | The role of F(18)-fluorodeoxyglucose positron emission tomography in guiding diagnosis and management in patients with known or suspected cardiac sarcoidosis |
| Q38167672 | The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy |
| Q40655323 | The role of PET quantification in cardiovascular imaging |
| Q37729879 | The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions |
| Q38394355 | The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases |
| Q37767374 | The role of noninvasive imaging in promoting cardiovascular health |
| Q37210598 | The role of positron emission tomography in the management of non-small cell lung cancer. |
| Q38947519 | The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging |
| Q45300713 | The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease |
| Q38585451 | The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues |
| Q26738588 | Therapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studies |
| Q38185979 | Therapeutic potential of p38 MAP kinase inhibition in the management of cardiovascular disease |
| Q37559632 | Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study |
| Q61727645 | Three-hour delayed imaging improves assessment of coronary 18F-sodium fluoride PET |
| Q37324445 | Thresholds for Arterial Wall Inflammation Quantified by (18)F-FDG PET Imaging: Implications for Vascular Interventional Studies |
| Q53096424 | Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study. |
| Q35099168 | Towards coronary plaque imaging using simultaneous PET-MR: a simulation study |
| Q35542584 | Towards understanding acute destabilization of vulnerable atherosclerotic plaques |
| Q34089975 | Translation of myocardial metabolic imaging concepts into the clinics |
| Q36553346 | Type 2 diabetes enhances arterial uptake of choline in atherosclerotic mice: an imaging study with positron emission tomography tracer ¹⁸F-fluoromethylcholine |
| Q42669148 | Ultrasonic Transducer-Guided Electrochemical Impedance Spectroscopy to Assess Lipid-Laden Plaques |
| Q47960412 | Unraveling Vascular Inflammation: From Immunology to Imaging. |
| Q28066956 | Unstable carotid artery plaque: new insights and controversies in diagnostics and treatment |
| Q34465991 | Uptake of aortic 18F-FDG is correlated with low-density lipoprotein cholesterol and leptin in a general population |
| Q46423027 | Uptake of inflammatory cell marker [11C]PK11195 into mouse atherosclerotic plaques |
| Q30401532 | Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies |
| Q51371134 | Utility of high fat and low carbohydrate diet in suppressing myocardial FDG uptake. |
| Q38038678 | Validation of FDG uptake in the arterial wall as an imaging biomarker of atherosclerotic plaques with 18F-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT). |
| Q62711621 | Value Based Imaging for Coronary Artery Disease: Implications for Nuclear Cardiology and Cardiac CT |
| Q90378385 | Value of simultaneous assessment of cardiac functions by PET/MRI |
| Q38628616 | Variability in quantitative analysis of atherosclerotic plaque inflammation using 18F-FDG PET/CT |
| Q46678573 | Vascular FDG uptake: further steps toward clinical acceptance |
| Q37868709 | Vascular imaging with positron emission tomography. |
| Q38957484 | Vascular targeting of nanoparticles for molecular imaging of diseased endothelium |
| Q26781925 | Vessel Wall Imaging of the Intracranial and Cervical Carotid Arteries |
| Q38135890 | What can we learn about valvular heart disease from PET/CT? |
| Q37862133 | What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate? |
| Q35148805 | What nuclear cardiology can learn from nuclear oncology |
| Q35676899 | [18F]FDG Accumulation in Early Coronary Atherosclerotic Lesions in Pigs |
| Q53056985 | [¹⁸F-NaF PET-CT: a new method for imaging of ruptured and rupture-endangered atherosclerotic plaques]. |
Search more.